Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
| Date | Title | Source |
|---|---|---|
| 2022-10-25 3:7:23 am | Not The Buyout Offer That Myovant Shareholders Hoped For | SeekingAlpha |
| 2022-10-13 4:0:0 am | ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China | GlobeNewswire |
| 2022-09-13 6:20:15 am | After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff | Benzinga |
| 2022-09-13 4:0:0 am | ObsEva Announces Progress on Restructuring Initiatives | GlobeNewswire |
| 2022-08-30 11:56:46 am | This Women Health Stock Gets Analyst Downgrade On 'Approvability Issues, Restructuring' | Benzinga |
| 2022-08-21 10:0:0 pm | ObsEva Receives Nasdaq Non-Compliance Notice | GlobeNewswire |
| 2022-08-17 1:1:0 pm | ObsEva Files Second Quarter 2022 Financial Statements | GlobeNewswire |
| 2022-08-03 9:0:4 am | All You Need to Know About ObsEva SA (OBSV) Rating Upgrade to Buy | Zacks |
| 2022-08-01 4:0:0 am | ObsEva Announces $31 million Debt Retirement and $11 million Debt Refinancing | GlobeNewswire |